Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise
By Jonathan StempelJuly 1 (Reuters) - A U.S. appeals court on Wednesday upheld two patents for Amgen Inc's multibillion-dollar rheumatoid arthritis drug...
By Jonathan StempelJuly 1 (Reuters) - A U.S. appeals court on Wednesday upheld two patents for Amgen Inc's multibillion-dollar rheumatoid arthritis drug...